South Korea
· Delayed Price · Currency is KRW Cellid, Statistics
Total Valuation
Cellid, has a market cap or net worth of KRW 117.12 billion. The enterprise value is 113.55 billion.
| Market Cap | 117.12B |
| Enterprise Value | 113.55B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Cellid, has 21.10 million shares outstanding. The number of shares has increased by 49.30% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 21.10M |
| Shares Change (YoY) | +49.30% |
| Shares Change (QoQ) | +29.37% |
| Owned by Insiders (%) | 16.07% |
| Owned by Institutions (%) | 0.00% |
| Float | 17.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 35.53 |
| PB Ratio | 2.14 |
| P/TBV Ratio | 2.18 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.29 |
| EV / Sales | 49.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.63 |
Financial Position
The company has a current ratio of 5.15, with a Debt / Equity ratio of 0.19.
| Current Ratio | 5.15 |
| Quick Ratio | 4.56 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.80 |
| Interest Coverage | -14.45 |
Financial Efficiency
Return on equity (ROE) is -23.74% and return on invested capital (ROIC) is -12.60%.
| Return on Equity (ROE) | -23.74% |
| Return on Assets (ROA) | -10.80% |
| Return on Capital (ROIC) | -12.60% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +22.91% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +22.91% |
| 50-Day Moving Average | 5,336.00 |
| 200-Day Moving Average | 4,597.61 |
| Relative Strength Index (RSI) | 49.39 |
| Average Volume (20 Days) | 2,294,161 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cellid, had revenue of KRW 2.28 billion and -10.06 billion in losses. Loss per share was -688.09.
| Revenue | 2.28B |
| Gross Profit | 412.37M |
| Operating Income | -10.92B |
| Pretax Income | -10.06B |
| Net Income | -10.06B |
| EBITDA | -8.23B |
| EBIT | -10.92B |
| Loss Per Share | -688.09 |
Balance Sheet
The company has 14.11 billion in cash and 10.54 billion in debt, giving a net cash position of 3.57 billion or 169.04 per share.
| Cash & Cash Equivalents | 14.11B |
| Total Debt | 10.54B |
| Net Cash | 3.57B |
| Net Cash Per Share | 169.04 |
| Equity (Book Value) | 54.74B |
| Book Value Per Share | 2,593.81 |
| Working Capital | 13.27B |
Cash Flow
In the last 12 months, operating cash flow was -8.48 billion and capital expenditures -4.68 billion, giving a free cash flow of -13.16 billion.
| Operating Cash Flow | -8.48B |
| Capital Expenditures | -4.68B |
| Free Cash Flow | -13.16B |
| FCF Per Share | -623.46 |
Margins
| Gross Margin | 18.06% |
| Operating Margin | -478.30% |
| Pretax Margin | -440.53% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Cellid, does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -49.30% |
| Shareholder Yield | -49.30% |
| Earnings Yield | -12.40% |
| FCF Yield | -11.23% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cellid, has an Altman Z-Score of 0.47. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.47 |
| Piotroski F-Score | n/a |